ProShares UltraShort Health Care
3 hedge funds and large institutions have $279K invested in ProShares UltraShort Health Care in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
481% more capital invested
Capital invested by funds: $48K → $279K (+$231K)
258% more call options, than puts
Call options by funds: $33.2M | Put options by funds: $9.28M
200% more funds holding
Funds holding: 1 → 3 (+2)
4.7% more ownership
Funds ownership: 0.98% → 5.68% (+4.7%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$228K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.91K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$18.8K |
RXD Hedge Fund Activity: Q1 2018 in Review
3 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q1 2018, worth a combined $279K — up 481% from $48K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RXD positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $228K. The largest seller was UBS Group, cutting an estimated $18.8K.
- 3 institutional investors held ProShares UltraShort Health Care (RXD) as of Q1 2018, up from 1 in Q4 2017.
- Funds reported $279K of ProShares UltraShort Health Care stock for Q1 2018, up 481% quarter-over-quarter.
- 2 funds opened new ProShares UltraShort Health Care positions in Q1 2018 and 0 closed out, a net change of +2 holders.
- The largest ProShares UltraShort Health Care buyer in Q1 2018 was Susquehanna International Group, an estimated $228K added.
- The largest ProShares UltraShort Health Care seller in Q1 2018 was UBS Group, an estimated $18.8K sold.
Based on aggregated 13F filings for Q1 2018.